Brian M. Frier

The Queen's Medical Research Institute — United Kingdom

Medicine · Health Sciences

72h-index20.2kcitations386works2.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Diabetes Management and Research(254), Diabetes and associated disorders(107), Diabetes Treatment and Management(90), Hyperglycemia and glycemic control in critically ill and hospitalized patients(72), Pancreatic function and diabetes(70)

Publications382 total

UK Resuscitation Advanced Life Support Guidelines: Should the Paradigm be Extended?
Diabetes Therapy·2025Open Access
Importance of targeting post‐prandial hyperglycaemia to achieve <scp>HbA1c</scp> goals in insulin glargine‐treated subphenotypes of type 2 diabetes
Diabetes Obesity and Metabolism·2025Open Access
Author response for "Importance of targeting post‐prandial hyperglycaemia to achieve &lt;scp&gt;HbA1c&lt;/scp&gt; goals in insulin glargine‐treated subphenotypes of type 2 diabetes"
2025
Severe hypoglycaemia and diabetic ketoacidosis in adults presenting to a hospital emergency department: Adverse prognostic markers for survival in type 2 diabetes and the role of <scp>SGLT2</scp> inhibitors
Diabetic Medicine·2024· 3 citedOpen Access
Effects of atmospheric pressure change during flight on insulin pump delivery and glycaemic control of pilots with insulin-treated diabetes: an in vitro simulation and a retrospective observational real-world study
Diabetologia·2024· 10 citedOpen Access
Young adult-onset type 2 diabetes heralds a poor prognosis
The Lancet Diabetes & Endocrinology·2024· 1 cited
Diabetes and Driving: A Statement of the American Diabetes Association
Diabetes Care·2024· 4 citedOpen Access
Responses to Basal Insulin Glargine (300 U/mL and 100 U/mL) with or Without Pre-prandial Insulin in Pre-treated Subphenotypes of Type 2 Diabetes: Insights from a Post Hoc Analysis
Diabetes Therapy·2024· 1 citedOpen Access
Social Aspects of Diabetes
2024
Treatment responses to basal insulin glargine 300 U/ml and glargine 100 U/ml in newly defined subphenotypes of type 2 diabetes: A post hoc analysis of the EDITION 3 randomized clinical trial
Diabetes Obesity and Metabolism·2023· 3 citedOpen Access
Author response for "Treatment responses to basal insulin glargine 300 U/ml and glargine 100 U/ml in newly defined subphenotypes of type 2 diabetes: A post hoc analysis of the EDITION 3 randomized clinical trial"
2023
Author response for "Treatment responses to basal insulin glargine 300 U/ml and glargine 100 U/ml in newly defined subphenotypes of type 2 diabetes: A post hoc analysis of the EDITION 3 randomized clinical trial"
2023
Does sensor technology lower the prevalence of impaired hypoglycaemia awareness in type 1 diabetes?
Diabetic Medicine·2023Open Access
Continuous Glucose Monitoring by Insulin-Treated Pilots Flying Commercial Aircraft Within the ARA.MED.330 Diabetes Protocol: A Preliminary Feasibility Study
Diabetes Technology & Therapeutics·2023· 5 cited
Severe hypoglycaemia in adults presenting to a hospital emergency department: Clinical characteristics, comorbidities, and mortality outcomes
Diabetes Obesity and Metabolism·2023· 3 citedOpen Access
Author response for "Severe hypoglycaemia in adults presenting to a hospital emergency department: Clinical characteristics, comorbidities, and mortality outcomes"
2023
Response to insulin glargine 100 U/mL treatment in newly-defined subgroups of type 2 diabetes: Post hoc pooled analysis of insulin-naïve participants from nine randomised clinical trials
Primary care diabetes·2023· 5 citedOpen Access
Recurrent hypoglycaemia in a young woman with type 1 diabetes
2023
Distribution and characteristics of newly-defined subgroups of type 2 diabetes in randomised clinical trials: Post hoc cluster assignment analysis of over 12,000 study participants
Diabetes Research and Clinical Practice·2022· 10 citedOpen Access
Young‐onset type 2 diabetes: A neglected group requiring urgent attention
Diabetic Medicine·2022· 11 cited
page 1 of 20Next →

Frequent Co-authors

Ian J. Deary(17), Mark W. J. Strachan(8), Jackie F. Price(6), Rory J. McCrimmon(5), David Hepburn(5), Petros Perros(4), Rebecca M. Reynolds(4), Nicola N. Zammitt(3), J. Geddes(3), Rohana J. Wright(3), Amanda Lee(3), Graham Leese(2), Fiona M.E Ewing(2), Linda Gonder‐Frederick(2), Simon Heller(2), J.E. Schopman(2), Kate V. Allen(2), Andrew J. Sommerfield(2), Stewart C. Ferguson(2), Annette Blane(2)